Alprazolam increases dehydroepiandrosterone concentrations

Journal of Clinical Psychopharmacology

Volumn 19, Issue 2, 1999, Pages 114-124

  Kroboth, Patricia D ^a   Salek, Firoozeh S ^a   Stone, Roslyn A ^b   Bertz, Richard J ^a   Kroboth III, Frank J ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALPRAZOLAM; HYDROCORTISONE; IODINE 125; NEUROSTEROID; PRASTERONE; PRASTERONE SULFATE;

ADULT; AGE; AGED; AMNESIA; ANXIETY NEUROSIS; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; FEMALE; GABAERGIC SYSTEM; HORMONE BLOOD LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; RADIOIMMUNOASSAY; SEDATION;

ADULT; AGE FACTORS; AGED; ALPRAZOLAM; DEHYDROEPIANDROSTERONE; HUMANS; HYDROCORTISONE; MALE; PSYCHOMOTOR PERFORMANCE; TIME FACTORS;

EID: 0032929571     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199904000-00005     Document Type: Article

References (67)

1. Evans RL. Alprazolam (Xanax, the Upjohn Company). Drug Intell Clin Pharm 1981;15:633-8.
2. Feighner JP, Aden GC, Fabre L, Rickels K, Smith WT. Comparison of alprazolam, imipramine, and placebo in the treatment of depression. JAMA 1983;249:3057-64.
3. Dawson GW, Jue SG, Brogden AB. Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression. Drugs 1984;27:132-47.
4. Ellinwood EH, Heatherly DG, Nikaido AM, Bjornsson TD, Kilts C. Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam. Psychopharmacology (Berl) 1985;86:392-9.
5. Greenblatt DJ, Harmatz JS, Shader RI. Plasma alprazolam concentrations: relation to efficacy and side effects in the treatment of panic disorder. Arch Gen Psychiatry 1993;50:715-22.
6. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986;232:1004-7.
7. A receptor complex. J Pharmacol Exp Ther 1987;241: 346-52.
8. Bertz RJ, Kroboth PD, Kroboth FJ, Reynolds IJ, Salek F, Wright CE, Smith RB. Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects. J Pharmacol Exp Ther 1997;281:1317-29.
9. A receptor shows a ligand-gated receptor super-family. Nature 1987;328:221-7.
10. A receptor. Mechanism of action and physiological significance. Prog Neurobiol 1992;38:379-95.
11. A receptor channels. Annu Rev Neurosci 1994;17:569-602.
12. Glue P, Wilson SJ, Nutt D. The role of the benzodiazepine receptor in anxiety. In: Hallstrom C, ed. Benzodiazepine dependence. New York: Oxford University Press, 1993:71-94.
13. Bruni G, Dal Pra P, Dotti MT, Segre G. Plasma ACTH and cortisol levels in benzodiazepine-treated rats. Pharmacol Res Commun 1980;12:163-75.
14. Zemishlany Z, McQueeney R, Gabriel SM, Davidson M. Neuroendocrine and monoaminergic responses to acute administration of alprazolam in normal subjects. Neurobiology 1990;23:124-8.
15. Curtis GC, Abelson JL, Gold PW. Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment. Biol Psychiatry 1997;41:76-85.
16. Vande Wiele RL, MacDonald PC, Gurpide E, Lieberman S. Studies on the secretion and interconversion of the androgens. In: Pincus G, ed. Recent progress in hormone research. New York: Academic Press, 1963:275-310.
17. Montanini V, Simoni M, Chiossi G, Baraghini GF, Velardo A, Baraldi E, Marrama P. Age-related changes in plasma dehydroepiandrosterone sulphate, cortisol, testosterone and free testosterone circadian rhythms in adult men. Horm Res 1988; 29:1-6.
18. Majewska MD. Steroids and brain activity: essential dialogue between body and mind. Biochem Pharmacol 1987;36:3781-8.
19. Nieschlag E, Loriaux DL, Ruder HJ, Zucker IR, Kirschner MA, Lipsett MB. The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J Endocrinol 1973;57:123-34.
20. Majewska MD, Schwartz RD. Prognenolone-sulfate an endogenous antagonist of the γ-aminobutyric acid receptor complex in brain? Brain Res 1987;404:355-60.
21. Rosenfeld RS, Rosenberg BJ, Fukushima DK, Hellman L. 24-hour secretory pattern of dehydroisoandrosterone and dehydroisoandrosterone sulfate. J Clin Endocrinol Metab 1975;40:850-5.
22. Rosenfeld RS, Hellman L, Roffwarg H, Weitzman ED, Fukushima DK, Gallagher TF. Dehydroisoandrosterone is secreted episodically and synchronously with cortisol by normal man. J Clin Endocrinol 1971;33:87-92.
23. Regelson W, Loria R, Kalimi M. Dehydroepiandrosterone (DHEA) - the "mother steroid" I. Immunologic action. Ann N Y Acad Sci 1994;719:553-63.
24. Birkenhager-Gillesse EG, Derksen J, Lagaay AM. Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over. Ann N Y Acad Sci 1994;719:543-52.
25. Kishimoto Y, Hoshi M. Dehydroepiandrosterone sulphate in rat brain: incorporation from blood and metabolism in vivo. J Neurochem 1972;19:2207-15.
26. Zumoff B, Bradlow HL. Sex difference in the metabolism of dehydroisoandrosterone sulfate. J Clin Endocrinol Metab 1980; 51:334-6.
27. Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J Clin Endocrinol Metab 1996;81:3951-60.
28. Labrie F, Bélanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82:2396-402.
29. Sulcova J, Hill M, Hampl R, Starka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol 1997;154:57-62.
30. Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 1992;75:1002-4.
31. Carlstrom K, Brody S, Lunell N-O, Lagrelius A, Mollerstrom G, Pousette A, Rannevik G, Stege R, von Schoultz B. Dehydroepiandrosterone sulphate and dehydroepiandrosterone in serum: differences related to age and sex. Maturitas 1988;10:297-306.
32. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59:551-5.
33. Pavlov EP, Harman SM, Chrousos GP, Loriaux DL, Blackman MR. Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men. J Clin Endocrinol Metab 1986;62:767-72.
34. Migeon CJ, Keller AR, Lawrence B, Shepard TH. Dehydroepiandrosterone and androsterone levels in human plasma effect of age and sex: day-to-day and diurnal variations. J Clin Endocrinol Metab 1957;17:1051-62.
35. Baulieu E-E. Steroid hormones in the brain: several mechanisms? In: Fuxe K, Gustafsson J-A, Wetterberg L, eds. steroid hormone regulation of the brain. New York: Pergamon Press, 1991:3-29.
36. Hu ZY, Bourreau E, Jung-testas I, Robel P, Baulieu E-E. Neurosteroids oligodendrocyte mitochondria convert cholesterol to pregnenolone. Proc Natl Acad Sci U S A 1987;84:8215-9.
37. Corpechot C, Robel P, Axelson M, Sjovall J, Baulieu E. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci U S A 1981;78:4704-7.
38. Robel P, Baulieu E-E. Neurosteroids biosynthesis and function. Trends Endocrinol Metab 1994;5:1-8.
39. Robel P, Bourreau R, Corpechot C, Dang DC, Halberg F, Clarke C, Haug M, Schlegel ML, Synguelakis M, Vourch C, Baulieu EE. Neuro-steroids: 3α-hydroxy-^5-derivatives in rat and monkey brain. J Steroid Biochem 1987;27:649-55.
40. Baulieu E, Robel P, Vatier O, Haug M, LeGoascogne C, Bourreau E. Neurosteroids: pregnenolone and dehydroepiandrosterone in the brain. In: Fuxe K, Agnati LF, eds. Receptor-receptor interactions. Basingstoke, Hampshire: MacMillan Press, 1987:89-104.
41. scc in rat brain. Science 1987;237:1212-5.
42. Majewska MD, Mienville J-M, Vicini S. Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci Lett 1988;90:279-84.
43. A receptor. Brain Res 1990;526:143-6.
44. A receptor. Neuroscience 1991;45:127-35.
45. Morales AJ, Nolan JJ, Nelson JC, Yen SSM. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360-7.
46. Friess E, Trachsel L, Guldner J, Schier T, Steiger A, Holsboer F. DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am J Physiol 1995;268:E107-E113.
47. Barrett-Connor E, Edelstein SL. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the rancho bernardo study. J Am Geriatr Soc 1994; 42:420-3.
48. Baker EL, Letz RE, Fidler AT, Shalat S, Plantamura D, Lyndon M. A computer-based neurobehavioral evaluation system for occupational and environmental epidemiology: methodology and validation studies. Neurobehav Toxicol Teratol 1985;7:369-77.
49. SAS Institute I. SAS/STAT User's Guide, Version 6. Cary, NC: SAS Institute, Inc., 1990.
50. Ohashi M, Kato K, Nawata H, Ibayashi H. Adrenocortical responsiveness to graded ACTH infusions in normal young and elderly human subjects. Gerontology 1986;32:43-51.
51. Kalogeras KT, Calogero AE, Kuribayiashi T, Khan I, Gallucci WT, Kling MA, Chrousos GP, Gold PW. In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications. J Clin Endocrinol Metab 1990;70:1462-71.
52. Calogero AE, Gallucci WT, Chrousos GP, Gold PW. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res 1988;463:28-36.
53. Calogero AE, Gallucci WT, Tomai TP, Loriaux DL, Chrousos GP, Gold PW. Inhibition of corticotropin releasing hormone secretion by GABA A and GABA B receptor action in vitro: clinical implications. In: D'Agata R, Chrousos GP, eds. Recent advances in adrenal regulation & function. New York: Raven Press, 1988:279-84.
54. Parker CR Jr, Azziz R, Potter HD, Boots LR. Adrenal androgen production in response to adrenocorticotropin infusions in men. Endocr Res 1996;22:717-22.
55. Svec F, Shawar A. The acute effect of a noontime meal on the serum levels of cortisol and DHEA in lean and obese women. Psychoneuroendocrinology 1997;22: S115-S119.
56. Abelson JL, Curtis GC. Hypothalamic-pituitary-adrenal axis activity in panic disorder. Arch Gen Psychiatry 1996;53:323-31.
57. Roy-Byrne PP, Dager SR, Cowley DS, Vitaliano PP, Dunner DL. Relapse and rebound following discontinuation of benzodiazepine treatment of panic attacks: alprazolam versus diazepam. Am J Psychiatry 1989;146:860-5.
58. A receptor complex reveals that it may act via the picrotoxin site. J Pharmacol Exp Ther 1997;282:827-33.
59. Carette B, Poulain P. Excitatory effect of dehydroepiandrosterone, its sulphate ester and pregnenolone sulphate, applied by iontophoresis and pressure, on single neurones in the septo-preoptic area of the guinea pig. Neurosci Lett 1984;45: 205-10.
60. Melchior CL, Ritzmann RF. Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol Biochem Behav 1994;47:437-41.
61. Flood JF, Roberts E. Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res 1988;448:178-81.
62. Flood JF, Smith GE, Roberts E. Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res 1988; 447:269-78.
63. Mellon SH, Deschepper CF. Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res 1993;629:283-92.
64. Robel P, Baulieu E. Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. Ann N Y Acad Sci 1995;774:82-110.
65. Lacroix C, Fiet J, Benais J-P, Gueux B, Bonete R, Villette J-M, Gourmel B, Dreux C. Simultaneous radioimmunoassay of progesterone, androst-4-enedione, pregnenolone, dehydroepiandrosterone and 17-hydroxyprogesterone in specific regions of human brain. J Steroid Biochem 1987;28:317-25.
66. Rubinow DR, Post RM, Savard R, Gold PW. Cortisol hypersecretion and cognitive impairment in depression. Arch Gen Psychiatry 1984;41:279-83.
67. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 1997;41:311-8.